Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
3301
DELISTED
bluebird bio
BLUE
| $231K | ﹤0.01% |
27,652
-1
| -0% | -$9 |
|
3302
HireQuest
HQI
$180M
| $230K | ﹤0.01% |
16,229
| – | – |
|
3303
Microvast
MVST
$269M
| $229K | ﹤0.01% |
+110,771
| New | +$82K |
|
3304
Aemetis
AMTX
$106M
| $229K | ﹤0.01% |
85,177
-236
| -0.3% | -$742 |
|
3305
Ultralife
ULBI
$86.4M
| $226K | ﹤0.01% |
30,387
| – | – |
|
|
SUNS
3306
Sunrise Realty Trust
SUNS
$106M
| $226K | ﹤0.01% |
16,067
| – | – |
|
3307
Oppenheimer Holdings
OPY
$1.14B
| $224K | ﹤0.01% |
+3,500
| New | +$203K |
|
3308
LiveWire
LVWR
$371M
| $224K | ﹤0.01% |
46,511
+5,968
| +15% | +$35.1K |
|
3309
Sportsman's Warehouse
SPWH
$44.5M
| $222K | ﹤0.01% |
83,227
-94,686
| -53% | -$237K |
|
|
RDNW
3310
RideNow Group
RDNW
$238M
| $222K | ﹤0.01% |
40,804
-3,414
| -8% | -$18.9K |
|
3311
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| $220K | ﹤0.01% |
2,214
-337
| -13% | -$34.9K |
|
3312
iShares Core MSCI Europe ETF
IEUR
$8.97B
| $220K | ﹤0.01% |
+4,080
| New | +$232K |
|
3313
Stem
STEM
$48.4M
| $220K | ﹤0.01% |
18,203
| – | – |
|
|
MPX
3314
DELISTED
Marine Products Corp
MPX
| $219K | ﹤0.01% |
23,829
-3,419
| -13% | -$32.9K |
|
3315
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.14B
| $218K | ﹤0.01% |
8,836
-4,191
| -32% | -$104K |
|
3316
Tenaya Therapeutics
TNYA
$161M
| $218K | ﹤0.01% |
152,588
| – | – |
|
3317
Acumen Pharmaceuticals
ABOS
$155M
| $218K | ﹤0.01% |
126,747
+18,004
| +17% | +$43.3K |
|
|
TECX
3318
Tectonic Therapeutic
TECX
$529M
| $218K | ﹤0.01% |
+4,711
| New | +$199K |
|
3319
Mammoth Energy Services
TUSK
$128M
| $212K | ﹤0.01% |
70,674
+7,064
| +11% | +$26K |
|
3320
iShares Select U.S. REIT ETF
ICF
$2.09B
| $212K | ﹤0.01% |
+3,513
| New | +$224K |
|
3321
Lineage Cell Therapeutics
LCTX
$269M
| $209K | ﹤0.01% |
416,223
| – | – |
|
3322
Gevo
GEVO
$360M
| $208K | ﹤0.01% |
99,561
-1,500
| -1% | -$2.84K |
|
3323
Lifetime Brands
LCUT
$191M
| $207K | ﹤0.01% |
35,087
| – | – |
|
|
GOCO
3324
DELISTED
GoHealth
GOCO
| $206K | ﹤0.01% |
15,371
| – | – |
|
3325
Caesarstone
CSTE
$72.3M
| $206K | ﹤0.01% |
48,363
| – | – |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.